Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
More like Running Mouth Robert... how irritating was THAT to listen to! Just because Missling isn't revealing the details of their communications with RAs, Robert thinks they're doing nothing. How naïve is that! And the FUDsters believe Robert. How funny!
True... biotech is not for everyone!
It has been posted here several times... Missling stated mid last year that they would wait for the Excellence trial to complete, in order to pursue the PR Voucher (~$100M). That may still be in the cards, depending upon the outcome of the FDA review of all the Rett data.
Apologies for the question; I follow this board loosely... What exactly is EDEN... the automated process? Thanks!
According to the premarket reaction to the conf. call, it appears the "market" is impressed by the information Missling provided.
Glad to have reloaded, once again, well into the $5s. Let's see if this is real or if the collusively manipulative HFs do their thing once again and crash the price, behind their choir of FUDsters.
He most certainly is an expert... bullschitter
You're so... unbelievable.
It's obvious to tell when you lie... you post it.
Unfortunately, they don't make a flyswatter large enough for the 33+ FUDsters, who post nonsense daily.
We just have to cover our food, while we wait for the peer-review, MAA submission, and whatever RA news we learn about Rett.
mikey, you, of all people, should know that the collusive network are in control of the price. With 20M short shares, they're going to keep it low before they have to start/resume covering. It's a corrupt network, along with their paid clowns polluting msg boards with their fake narratives.
For those who don't know by now... it's not a true "market" we're dealing with, especially in biotech. It's run by a collusive network that includes HFs & MMs who collectively manage the price. For their smokescreen, they employ the services of so-called "journalists" (like AF) to produce fake news about certain targeted biotechs... along with the efforts of dozens of hired social-media FUDsters to troll msg brds and spew negative nonsense. I think everyone has seen the list.
Many investors and observers have their suspicions and beliefs that these HFs/MMs also have their hands in BP's pocket. It certainly benefits BP if promising companies can be bought at the cheap... saving them a few $billion.
Refer to Xena's post about an analyst's perspective with NWBO... It's not just unique to AVXL.
You conveniently picked a short 24-wk study for donepezil. It has been shown in additional studies, donepezil loses its effectiveness after 6 months to being nearly nonexistent. Whereas, blarcamesine slowed cognitive decline by 45% compared to placebo at 48 weeks. Mean difference in ADAS-Cog score change of -1.85 points (p=0.033).
CDR-SB is a combo test of both cognition and function where blarcamesine reduced clinical decline of cognition and function by 27% with mean score difference of -0.42 points (p=0.040) at 48 weeks.
Additionally, ADAS-Cog and CDR-SB with LSM p-values<0.025, provide further evidence of stat. sig. improvements and trial success.
Then, there's the identification of two key biomarkers (Aß42/40 ratio and brain volume stabilization)... not seen with donepezil, nor the mabs.
Very much looking forward to the additional data coming in the peer-reviewed journal article due out soon.
WRONG! Anavex owns the patents, not Missling. Missling is just the author or a co-author.
A strong patent portfolio is a necessity in biotech... technology in general.
How about all those collusive naked short positions? Your handlers are piling them up with a ton of FTD.
The discovery process will be quite revealing... after the MTD is denied.
Your handlers are quite busy with their manipulation to try to discourage retail investors.
This, too, shall pass and you and your brethren will be long gone with approval announcement.
We all know which team you're on. You're not fooling anyone. I've seen you on other boards spewing the same schitt.
We know... it's a job. Not worried at all about this company's prospects with approval this year.
Like I said... waiting for more purchase opportunities. Next buying target is .50... if it gets there.
Added the second 50k shares... There's more waiting if the opportunity arises.
Tell your handlers 'thanks' for me!
LOL... FUDster trying hard to deny that value buyers are buying. So, funny!
I added 50k shares and will add another 50k this week, if not by end of day.
By the price manipulation, we must be getting close to approval. This looks like a good area to start loading up.
But you have no problem with the 33 FUDsters who post lies every day?
George actually speaks the truth, but unfortunately gets carried away with his predictions.
I believe we know your agenda.
In case you missed the team FUD roster...
If you don't have a problem with FUDsters posting lies 24x7, then people shouldn't have a problem with george, or anyone else, posting truths and facts, regardless of how repetitive they are; they're still truths... and newbies would benefit seeing them. The daily lies from 33 FUDsters needs counter fire.
Keep it up george... continue with your truths about Anavex.
He wasn't assigned to this board until recently. He apparently was assigned to relieve another 👺.
Two misguided and ill-informed statements...
MM pegging the price at $6.66 seems rather ominous. 😏
AVXL board is textbook FUD... 33 and counting.
Boy, you're one persistent FUDster, aren't you? Glad you found yourself high up in the idiocy category.
What level are FUDsters? Must be quite low.
Still worried about my phone call with IR... too funny!
Oh god, no... the flatulence would be deadly!
All of my expectations have been based on NDA submissions, now add MAA submission. 👍️
What have we learned? Who are all the FUDsters here... all 33 of them that sit on this board alone and spew out untruths and make false inferences.
The WGT believers will be proven right, simply because all of the results are pointing in that direction.
Commercialization likely yet this year, if the MAA and NDAs are filed in due time.
Hindsight is always 20/20. It's rather evident that even the consultant who proposed the trial design also didn't expect a placebo result to be amazingly large... even larger than the trofinetide treated response. I guess that's what can happen when there are no side effects to bias the blinded trial, and you get very hopeful parents.
My point... I'm glad you concur that blarcamesine is a very efficacious therapy for Rett patients.
If you see it, then surely the RAs will, as well.
We see those frivolous actions for what they really are... your handlers telling their ambulance chasers to put out crap for their manipulation schemes. Apparently, they don't believe their paid soldiers are very effective of late.
Seems to me you're implying that the trial would've been successful if only they ran a larger trial. Good to know that you believe the drug is quite effective. I'm sure the RAs will see it that way too, especially with the OLE and RWE data showing QoL improvements and seizure reductions.
So hilarious watching FUDsters play with themselves. LOL
Boy, do you sound stressed! LOL
Oh, so you admit to being a FUDster... just not a stressed one. Got it.